Bactiquant Total Asset vs. Current Valuation

BACTIQ Stock  DKK 4.14  0.10  2.36%   
Based on Bactiquant's profitability indicators, Bactiquant AS may not be well positioned to generate adequate gross income at the moment. It has a very high risk of underperforming in December. Profitability indicators assess Bactiquant's ability to earn profits and add value for shareholders.
For Bactiquant profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Bactiquant to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Bactiquant AS utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Bactiquant's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Bactiquant AS over time as well as its relative position and ranking within its peers.
  
Check out Trending Equities.
Please note, there is a significant difference between Bactiquant's value and its price as these two are different measures arrived at by different means. Investors typically determine if Bactiquant is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bactiquant's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Bactiquant AS Current Valuation vs. Total Asset Fundamental Analysis

Comparative valuation techniques use various fundamental indicators to help in determining Bactiquant's current stock value. Our valuation model uses many indicators to compare Bactiquant value to that of its competitors to determine the firm's financial worth.
Bactiquant AS is number one stock in total asset category among its peers. It also is the top company in current valuation category among its peers reporting about  5.61  of Current Valuation per Total Asset. Comparative valuation analysis is a catch-all model that can be used if you cannot value Bactiquant by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Bactiquant's Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

Bactiquant Current Valuation vs. Total Asset

Total Asset is everything that a business owns. It is the sum of current and long-term assets owned by a firm at a given time. These assets are listed on a balance sheet and typically valued based on their purchasing prices, not the current market value.

Bactiquant

Total Asset

 = 

Tangible Assets

+

Intangible Assets

 = 
24.52 M
Total Asset is typically divided on the balance sheet on current asset and long-term asset. Long-term is the value of company property and other capital assets that are expected to be useable for more than one year. Long term assets are reported net of depreciation. On the other hand current assets are assets that are expected to be sold or converted to cash as part of normal business operation.
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.

Bactiquant

Enterprise Value

 = 

Market Cap + Debt

-

Cash

 = 
137.43 M
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.

Bactiquant Current Valuation vs Competition

Bactiquant AS is the top company in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Pollution & Treatment Controls industry is currently estimated at about (12.1 Billion). Bactiquant adds roughly 137.43 Million in current valuation claiming only tiny portion of equities listed under Pollution & Treatment Controls industry.

Bactiquant Profitability Projections

The most important aspect of a successful company is its ability to generate a profit. For investors in Bactiquant, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Bactiquant will eventually generate negative long term returns. The profitability progress is the general direction of Bactiquant's change in net profit over the period of time. It can combine multiple indicators of Bactiquant, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
Bactiquant AS develops and provides technology for the mobile and online surveillance of bacterial contamination levels in water. The company is based in 1998 and is based in Horsholm, Denmark. BactiQuant is traded on Copenhagen Stock Exchange in Denmark.

Bactiquant Profitability Driver Comparison

Profitability drivers are factors that can directly affect your investment outlook on Bactiquant. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Bactiquant position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Bactiquant's important profitability drivers and their relationship over time.

Use Bactiquant in pair-trading

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Bactiquant position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Bactiquant will appreciate offsetting losses from the drop in the long position's value.

Bactiquant Pair Trading

Bactiquant AS Pair Trading Analysis

The ability to find closely correlated positions to Bactiquant could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Bactiquant when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Bactiquant - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Bactiquant AS to buy it.
The correlation of Bactiquant is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Bactiquant moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Bactiquant AS moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Bactiquant can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching

Use Investing Themes to Complement your Bactiquant position

In addition to having Bactiquant in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Gold and Gold Mining Thematic Idea Now

Gold and Gold Mining
Gold and Gold Mining Theme
Large and mid-size companies, ETFs and funds that are either investing, exploring or producing, gold or indirectly involved in trading or making gold products. The Gold and Gold Mining theme has 100 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Gold and Gold Mining Theme or any other thematic opportunities.
View All  Next Launch

Other Information on Investing in Bactiquant Stock

To fully project Bactiquant's future profitability, investors should examine all historical financial statements. These statements provide investors with a comprehensive snapshot of the financial position of Bactiquant AS at a specified time, usually calculated after every quarter, six months, or one year. Three primary documents fall into the category of financial statements. These documents include Bactiquant's income statement, its balance sheet, and the statement of cash flows.
Potential Bactiquant investors and stakeholders can use historical trends found within financial statements to determine how well the company is positioned for the future. Although Bactiquant investors may work on each financial statement separately, they are all related. The changes in Bactiquant's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Bactiquant's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.